📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. (2022)

First Author: Dejnirattisai W

Attributed to: Structural studies of viruses and their interactions with cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)02844-0

PubMed Identifier: 34942101

Publication URI: http://europepmc.org/abstract/MED/34942101

Type: Journal Article/Review

Volume: 399

Parent Publication: Lancet (London, England)

Issue: 10321

ISSN: 0140-6736